View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Gemcitabine 900 / Docetaxel 75 / Bevacizumab 15, Soft Tissue Sarcoma
Protocol-ID: 573 V1.0 (Mini), GEMC900/DOCE75/BEVA15, Soft Tissue SarcomaIndication(s)
- Soft Tissue Sarcoma; ICD-10 C49.-
Links
- Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. [PMID]
- Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.08.2015